Brief: Immupharma Plc Announces Positive Guidance From FDA For IND Application Of P140 In CIDP
18/05/2023 07:34
May 18 (Reuters) - ImmuPharma PLC IMM.L :
* IMMUPHARMA PLC - POSITIVE PRE-IND MEETING WITH FDA
* IMMUPHARMA PLC - POSITIVE GUIDANCE FROM FDA PRE-IND MEETING SUPPORTS AN
IND
APPLICATION AND A PHASE 2/3 ADAPTIVE CLINICAL TRIAL OF P140 IN CIDP
* IMMUPHARMA PLC - APPLICATION FOR ORPHAN DRUG STATUS FOR CIDP WILL BE ALSO
SUBMITTED IN PARALLEL TO FULL IND APPLICATION
Source text for Eikon: ID:nRSR8612Za
Further company coverage: IMM.L
((Reuters.Briefs@thomsonreuters.com;))